Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Salicylazosulfapyridine in inflammatory bowel disease.

× No keyword cloud information.

41 in total

1. Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.

Authors: A HANNGREN; E HANSSON; N SVARTZ; S ULLBERG
Journal: Acta Med Scand Date: 1963-01

2. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.

Authors: S C TRUELOVE; G WATKINSON; G DRAPER
Journal: Br Med J Date: 1962-12-29

3. Regional enteritis: an evaluation of the present-day therapeutic management.

Authors: J A BARGEN
Journal: Ann Intern Med Date: 1957-11 Impact factor: 25.391

4. Chemotherapy and antibiotics in chronic ulcerative colitis.

Authors: M BLOCK; H M POLLARD
Journal: Gastroenterology Date: 1948-01 Impact factor: 22.682

5. The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro.

Authors: J Harris; E Q Archampong; C G Clark
Journal: Gut Date: 1972-10 Impact factor: 23.059

6. Distribution studies of salicylazosulfapyridine and its metabolites.

Authors: M A Peppercorn; P Goldman
Journal: Gastroenterology Date: 1973-02 Impact factor: 22.682

7. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.

Authors: S L Gorbach; L Nahas; A G Plaut; L Weinstein; J F Patterson; R Levitan
Journal: Gastroenterology Date: 1968-04 Impact factor: 22.682

8. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors: K M Das; M A Eastwood; J P McManus; W Sircus
Journal: N Engl J Med Date: 1973-09-06 Impact factor: 91.245

9. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.

Authors: P Riis; P Anthonisen; H R Wulff; O Folkenborg; O Bonnevie; V Binder
Journal: Scand J Gastroenterol Date: 1973 Impact factor: 2.423

10. Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease.

Authors: R J Rafoth
Journal: Am J Dig Dis Date: 1974-05

3 in total

1. Crohn disease. Newer aspects of etiology, diagnosis and therapy.

Authors:
Journal: West J Med Date: 1978-05

2. Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.

Authors: C Clerici; G Gentili; E Boschetti; C Santucci; A G Aburbeh; B Natalini; R Pellicciari; A Morelli
Journal: Dig Dis Sci Date: 1994-12 Impact factor: 3.199

Review 3. Comparative tolerability of therapies for ulcerative colitis.

Authors: Sandro Ardizzone; Gabriele Bianchi Porro
Journal: Drug Saf Date: 2002 Impact factor: 5.606

3 in total